Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Portola stock tumbled after disappointing phase 3 trial data
Portola stock tumbled after disappointing phase 3 trial data
Portola stock tumbled after disappointing phase 3 trial data
Submitted by
admin
on March 24, 2016 - 9:58am
Source:
Marketwatch
News Tags:
Portola Pharmaceuticals
clinical trials
venous thromboembolism
Headline:
Portola stock tumbled after disappointing phase 3 trial data
Do Not Allow Advertisers to Use My Personal information
